These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7076269)

  • 41. [Three pharmacokinetics programs are written in BASIC (author's transl)].
    Dally S; Duvelleroy M
    Therapie; 1980; 35(2):233-46. PubMed ID: 7414531
    [No Abstract]   [Full Text] [Related]  

  • 42. Structural identifiability of "first-pass" models.
    Venot A; Walter E; Lecourtier Y; Raksanyi A; Chauvelot-Moachon L
    J Pharmacokinet Biopharm; 1987 Apr; 15(2):179-89. PubMed ID: 3612500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic drug monitoring. Pharmacokinetic and pharmacodynamic principles.
    Howanitz JH; Howanitz PJ
    Clin Lab Med; 1981 Sep; 1(3):467-78. PubMed ID: 7346215
    [No Abstract]   [Full Text] [Related]  

  • 44. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of host factors on drug response. VII. Renal diseases.
    Vesell ES
    Ration Drug Ther; 1981 Nov; 15(11):1-9. PubMed ID: 7345476
    [No Abstract]   [Full Text] [Related]  

  • 46. [Kidney and drugs - urinary lithiasis. Pharmacokinetic glossary].
    Balant L
    Rev Med Suisse Romande; 1980 Nov; 100(11):949-56. PubMed ID: 7466067
    [No Abstract]   [Full Text] [Related]  

  • 47. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symposium on drug protein binding. Biochemical, pharmacokinetic and clinical implications. Stockholm, March 26--28, 1980. Abstracts.
    Acta Pharm Suec; 1980; 17(2):65-104. PubMed ID: 7446140
    [No Abstract]   [Full Text] [Related]  

  • 49. [Planning for Phase I in clinico-pharmacological research].
    Dudeck J; Höbel W; Valk HU
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1625-8. PubMed ID: 4801608
    [No Abstract]   [Full Text] [Related]  

  • 50. The design of pharmacokinetic experiments for model discrimination.
    Lacey L; Dunne A
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):351-65. PubMed ID: 6502475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accuracy of pharmacokinetic estimates in ambulatory patients.
    Giannini VS; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1983 Jan; 40(1):44, 49. PubMed ID: 6823988
    [No Abstract]   [Full Text] [Related]  

  • 52. [Initial peak as a result of an adaptation (author's transl)].
    Kaemmerer K
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):211-4. PubMed ID: 7026205
    [No Abstract]   [Full Text] [Related]  

  • 53. Do you need a pharmacokinetic model, and, if so, which one?
    Wagner JG
    J Pharmacokinet Biopharm; 1975 Dec; 3(6):457-78. PubMed ID: 1206481
    [No Abstract]   [Full Text] [Related]  

  • 54. Nonscientific commentary. Pharmacokinetics and pharmacokinetic toxicity.
    Lemberger AP
    J Pharmacokinet Biopharm; 1975 Jun; 3(3):219-22. PubMed ID: 1159625
    [No Abstract]   [Full Text] [Related]  

  • 55. Time-dependent kinetics IV: Pharmacokinetic theory of enzyme induction.
    Levy RH; Lai AA; Dumain MS
    J Pharm Sci; 1979 Mar; 68(3):398-9. PubMed ID: 106109
    [No Abstract]   [Full Text] [Related]  

  • 56. [The pharmacokinetic basis of of the undesirable effects of drugs in the aged subject].
    Cheymol G; Biour M
    Therapie; 1983; 38(5):475-84. PubMed ID: 6670070
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetic assessment of the effect of age on the disposition and pharmacologic activity of drugs.
    Levy G
    Adv Exp Med Biol; 1978; 97():47-53. PubMed ID: 565579
    [No Abstract]   [Full Text] [Related]  

  • 58. Physiologically based pharmacokinetic modeling: principles and applications.
    Gerlowski LE; Jain RK
    J Pharm Sci; 1983 Oct; 72(10):1103-27. PubMed ID: 6358460
    [No Abstract]   [Full Text] [Related]  

  • 59. Structural identifiability and indistinguishability of compartmental models.
    Yates JW; Jones RD; Walker M; Cheung SY
    Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):295-302. PubMed ID: 19331592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of pharmacokinetic data using parametric models--1: Regression models.
    Sheiner LB
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):93-117. PubMed ID: 6747821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.